AbbVie Acquires Ichnos Glenmark’s Premier Myeloma Antibody for Almost $2 Billion

AbbVie Acquires Ichnos Glenmark’s Premier Myeloma Antibody for Almost $2 Billion

AbbVie Acquires Ichnos Glenmark’s Premier Myeloma Antibody for Almost $2 Billion